saRNA Database

Curated literature resource for saRNA research.

A curated literature resource for small activating RNA (saRNA) sequences, experimental conditions, and reported outcomes.

Developed at National Institute of Chemistry · Department of Synthetic Biology and Immunology

Public release available

Version 1.0.0 contains 4,706 observation-level records, 2,424 normalized sequence identities, and 114 literature and patent sources.

What are saRNAs?

Small activating RNAs (saRNAs) are short double-stranded RNAs that increase endogenous gene expression through RNA activation. They are being explored as research tools and potential therapeutics, including for targets that are difficult to address by conventional approaches. This database brings published saRNA sequences and their experimental context together to support analysis and more rational design.

Explore the database

Search records

Search sequences, genes, models, experimental conditions, and source publications.

Open the database

Review full details

Start with a compact table and expand any row to inspect every released field and its source context.

Use the archived release

Obtain and cite the complete versioned package from Zenodo.

Open the Zenodo archive

About the resource

The database brings together structured information from the saRNA literature, making published sequence and experimental information easier to find, review, cite, and reuse. It accompanies the Molecules review Small Activating RNAs: A Curated Database and an Overview of Rational Design Principles. Read the methods, citation guidance, and project information.

Help improve the database

Do you know of a relevant study or patent that is missing? Do you have unpublished data that you would like the curators to consider for a future release? Please review the contact and contribution guidance.

Proposed additions are reviewed for scope, provenance, permissions, and attribution before inclusion. Please do not submit confidential, personal, or patient-identifiable information.